Learn More
Drug-associated interstitial lung disease (ILD) is not uncommon, with diverse patterns ranging from benign infiltrates to the potentially fatal acute respiratory distress syndrome. As acute respiratory failure due to drug-associated ILD has an unpredictable onset and rapid time course, establishing a diagnosis is often difficult. An accurate diagnosis is(More)
The incidence of lung cancer has markedly increased in the past few decades and is still increasing in many countries worldwide. Lung cancer is a leading cause of death in many developed countries, and approximately 140 000 new cases are identified each year in the US alone (Green, 2004). The majority of patients with non-small-cell lung cancer (NSCLC) are(More)
Since 1984, the use of the official method for determining the responsibility of drugs in side-effects has been compulsory in France. This method offers, but does not define, different qualificatives for chronological and semeiological criteria. Consensus workshops have been set up to define the undesirable side-effects themselves and the different(More)
  • Ph. Camus
  • Revue francaise des maladies respiratoires
  • 1982
The literature is reviewed on patients developing respiratory symptoms while receiving D-Penicillamine, most of whom suffered from rheumatoid arthritis. The manifestations were (in decreasing frequency) bronchiolitis obliterans, interstitial pneumonitis, a Good pasture's like syndrome and bronchospasm. For each complication we discuss diagnostic criteria,(More)
Adverse medical side effects are an important health issue causing morbidity and mortality. Lungs, being a complex system are also involved. Cough, bronchospasms and buccopharyngeal oedema are the main drug-induced reactions at the airways level. With regard to pulmonary parenchyma, this can result in almost all forms of interstitial lung disease such as(More)
  • 1